Pharmafile Logo
Pharmafocus logo
Advanced Search

Shadow Commissioning Board goes live

October 31, 2011
Medical Communications Commissioning Board, DH, NHS

The NHS Commissioning Board, the new central and powerful committee that will co-ordinate the health service in England, has been …

News

UK researchers claim advance in chiral manufacturing

October 31, 2011
Manufacturing and Production Cambridge University, chiral manufacturig, chiral manufacturing

Researchers from the UK says a new technique which uses metal surfaces as templates to make drug compounds with specific …

News
Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …

Feature

Contract research news in brief

October 31, 2011
Manufacturing and Production, Research and Development CRO, manufacturing and production

PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …

News
Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011
Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …

News
peter_maag

Carsten Schroeder appointed interim president of Novartis Diagnostics

October 31, 2011
Sales and Marketing Novartis

Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …

Appointment
Swiss protest image

Novartis job cuts protest

October 31, 2011
Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production

Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …

News

Core products boost Merck’s results

October 31, 2011
Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis

Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment.  Worldwide sales …

News

Brilique gains NICE approval

October 31, 2011
Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel

AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …

News

Boehringer agrees Pradaxa kidney function warning

October 30, 2011
Sales and Marketing AF, EMA, Pradaxa, renal function

Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …

News

Dr Reddy’s says two plants clear FDA inspections

October 28, 2011
Manufacturing and Production Dr Reddy's, FDA 483s, India, generics

Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …

News

Emerging markets help Bayer through tough quarter

October 28, 2011
Sales and Marketing Bayer, Xarelto, emerging markets

Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …

News
picture_1

PM Society appoints new general manager

October 28, 2011
Medical Communications pm society

The Pharmaceutical Marketing Society has appointed Anneliese Cameron as its new general manager. Anneliese will be joining the Society on …

Appointment

Publicis merges digital agencies into larger group

October 28, 2011
Medical Communications Digitas Health, Razorfish, digital, publicis

Digital agencies Digitas Health and Razorfish Health are to be merged into the larger Publicis Healthcare Communications Group (PHCG).PHCG is …

News

AstraZeneca weathers patent expiry storm

October 27, 2011
Sales and Marketing AstraZeneca, AstraZenecca, q3 2011

 AstraZeneca saw its revenue decline in the third quarter due to an onslaught of patent expiries, but still saw its …

News

Lessons from the world of iPad detailing

October 27, 2011
Medical Communications

This is an article for those who have chosen the iPad as an e-detailing tool. It’s not an argument on …

Feature
Thought Leadership
Social moon image

Alex Butler leaves Janssen to set up Social Moon pharma network

October 27, 2011
Medical Communications Alex Bytler, Jansse, Janssen, comms

Social media guru Alex Butler has left Janssen to establish Social Moon, a digital-only marketing and comms agency for the …

News
Lansley speach

Lansley talks tough on failing hospitals

October 27, 2011
Medical Communications Andrew Lansley, NHS reforms

The health secretary Andrew Lansley says he will intervene to remove management boards of hospitals which can’t clear debts or …

News

Biogen’s MS drug hits phase III targets

October 27, 2011
Sales and Marketing BG-12, Biogen, MS

Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial.   BG-12 (dimethyl fumarate) tablets …

News
GSK logo

GSK sees strong Q3 after battling headwinds

October 27, 2011
Business Services, Sales and Marketing GSK, GSK. Q3, Q3

GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026